During the past decade, Ohio State University MS Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ohio State University MS Center" are "Multiple Sclerosis" (5 trials). Many other conditions were trialed in "Ohio State University MS Center" in a lesser frequency.

Most popular intervention types in "Ohio State University MS Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Fampridine-SR" (4 trials), "Placebo" (2 trials) and "Fampridine-SR b.i.d. (Twice Daily)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State University MS Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Ohio State University MS Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Ohio State University MS Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State University MS Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".